Sec Form 13G Filing - AMERIPRISE FINANCIAL INC (AMP) filing for Eiger BioPharmaceuticals Inc. (EIGR) - 2022-05-11

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Amendment #3

Under the Securities and Exchange Act of 1934

 

 

Eiger BioPharmaceuticals, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

28249U105

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

May 6, 2022

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

This Schedule is filed pursuant to Rule 13d-1(c)

The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 


CUSIP NO. 28249U105

 

  1)    

  Name of Reporting Person

 

  Ameriprise Financial, Inc.

 

  S.S. or I.R.S. Identification No. of Above Person

 

  IRS No. 13-3180631

  2)  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☒*

 

*   This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5)    

  Sole Voting Power

 

  0

   6)  

  Shared Voting Power

 

  7,283,232

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  7,590,126

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  7,590,126

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  17.56%

12)  

& #xA0; Type of Reporting Person

 

  HC


CUSIP NO. 28249U105

 

  1)    

  Name of Reporting Person

 

  Columbia Management Investment Advisers, LLC

 

  S.S. or I.R.S. Identification No. of Above Person

 

  IRS No. 41-1533211

  2)  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☒*

 

*   This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Minnesota

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5)    

  Sole Voting Power

 

  0

   6)  

  Shared Voting Power

 

  7,283,232

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  7,587,576

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  7,587,576

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  17.56%

12)  

  Type of Reporting Person

 

  IA


CUSIP NO. 28249U105

 

  1)    

  Name of Reporting Person

 

  Seligman Tech Spectrum Offshore Fund

 

  S.S. or I.R.S. Identification No. of Above Person

  2)  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☒*

 

*   This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Massachusetts

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5)    

  Sole Voting Power

 

  2,131,507

   6)  

  Shared Voting Power

 

  0

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  2,131,507

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  2,131,507

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  4.93%

12)  

  Type of Reporting Person

 

  OO


CUSIP NO. 28249U105

 

  1)    

  Name of Reporting Person

 

  Columbia Seligman Technology and Information Fund

 

  S.S. or I.R.S. Identification No. of Above Person

 

  IRS No. 13-3154449

  2)  

  Check the Appropriate Box if a Member of a Group

 

  (a)  ☐        (b)  ☒*

 

*   This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Massachusetts

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

   5)    

  Sole Voting Power

 

  2,319,150

   6)  

  Shared Voting Power

 

  0

   7)  

  Sole Dispositive Power

 

  0

   8)  

  Shared Dispositive Power

 

  2,319,150

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  2,319,150

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  5.37%

12)  

  Type of Reporting Person

 

  IV


1(a) Name of Issuer:    Eiger BioPharmaceuticals, Inc.
1(b) Address of Issuer’s Principal    2155 Park Boulevard
Executive Offices:    Palo Alto, CA 94306
2(a) Name of Person Filing:    (a) Ameriprise Financial, Inc. (“AFI”)
   (b) Columbia Management Investment Advisers, LLC (“CMIA”)
   (c) Seligman Tech Spectrum Offshore Fund (“Offshore Fund”)
   (d) Columbia Seligman Technology and Information Fund (“Tech Fund”)
   Persons (c) and (d) are sometimes referred to herein as the “Funds”.
2(b) Address of Principal Business Office:    (a) Ameriprise Financial, Inc.
   145 Ameriprise Financial Center
   Minneapolis, MN 55474
   (b) 290 Congress St.
   Boston, MA 02210
   (c) P.O. Box 309, Ugland House,
  

George Town, Grand Cayman KY1-1104,

Cayman Islands

   (d) 290 Congress St.
   Boston, MA 02210
2(c) Citizenship:    (a) Delaware
   (b) Minnesota
   (c) Cayman Islands
   (d) Massachusetts
2(d) Title of Class of Securities:    Common Stock
2(e) Cusip Number:    28249U105

 

3

Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):

Not applicable

 

4

Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.

CMIA and AFI do not directly own any shares of Common Stock of the issuer. As the investment adviser to the Funds and various other unregistered and registered investment companies and other managed accounts, CMIA may be deemed to beneficially own the shares reported herein by the Funds. Accordingly, the shares reported herein by CMIA include those shares separately reported herein by the Funds.

 


As the parent holding company of CMIA, AFI may be deemed to beneficially own the shares reported herein by CMIA. Accordingly, the shares reported herein by AFI include those shares separately reported herein by CMIA.

Each of AFI and CMIA, and the subsidiaries identified on the attached Exhibit I, disclaims beneficial ownership of any shares reported on this Schedule.

 

5

Ownership of 5% or Less of a Class: Not Applicable

 

6

Ownership of more than 5% on Behalf of Another Person:

To the knowl edge of AFI, CMIA and the Funds, no other persons besides AFI, CMIA and the Funds and those persons for whose shares of common stock CMIA and AFI report beneficial ownership have the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of the securities of the issuer reported herein. As of May 6, 2022, only the Tech Fund owned more than 5% of the class of securities reported herein.

Any remaining shares reported herein by CMIA are held by various other funds or accounts managed by CMIA which each have the right to receive any dividends paid by the issuer and could terminate their respective investment advisory relationship with CMIA and then subsequently direct the use of proceeds from the sale of the common stock owned by such fund or account. To CMIA’s knowledge, none of these other funds or accounts own more than 5% of the outstanding shares of the issuer as .

 

7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

AFI: See Exhibit I

 

8

Identification and Classification of Members of the Group:

Not Applicable

 

9

Notice of Dissolution of Group:

Not Applicable

 

10

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: May 11, 2022

 

Ameriprise Financial, Inc.
By:  

/s/ Michael G. Clarke

Name: Michael G. Clarke
Title: Senior Vice President, Head of Global Operations
Columbia Management Investment
Advisers, LLC
By:  

/s/ Michael G. Clarke

Name: Michael G. Clarke
Title: Senior Vice President, Head of Global Operations
Seligman Tech Spectrum Offshore Fund
By:  

/s/ David Litton

Name: David Litton
Title: Director
Columbia Seligman Technology and Information Fund
By:  

/s/ Michael G. Clarke

Name: Michael G. Clarke
Title: Chief Financial Officer and Principal Financial Officer
Contact Information
Mark D. Braley
Vice President
Head of Reporting and Data Management| Global Operations and Investor Services
Telephone: (617) 747-0663


Exhibit Index

 

Exhibit I

Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.

 

Exhibit II

Joint Filing Agreement